13 August 2021: Clinical Research
Percutaneous Argon-Helium Cryoablation for Small Hepatocellular Carcinoma Located Adjacent to a Major Organ or Viscus: A Retrospective Study of 92 Patients at a Single Center
Wei Zhang 1BCE* , Xudong Gao 1DF* , Jie Sun 1EF* , Jiamin Cheng 1B , Yanli Hu 2BE , Zheng Dong 1B , Huifang Kong 1BF , Huixin Zhang 1BF , Chunping Wang 1BG , Yongping Yang 1AG*DOI: 10.12659/MSM.931473
Med Sci Monit 2021; 27:e931473
Figure 2 Images from a 51-year-old man who underwent cryoablation for small hepatocellular carcinoma (HCC) located in liver segment I. (A) Magnetic resonance imaging (MRI) axial scan in the arterial phase before cryoablation; 1 nodule located in liver segment I (white arrow). (B) Cryoprobes were inserted into the tumor under CT guidance. (C) MRI scan preformed 3 days after cryoablation indicated technical success. (D) MRI scanning shows that local tumor recurrence (white arrow) was not found at the 18-month follow-up.